GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study †

By Papanikolaou E.G.   Pados G.   Grimbizis G.   Bili E.   Kyriazi L.   Polyzos N.P.   Humaidan P.   Tournaye H.   Tarlatzis B.  

Human Reproduction, Vol. 27, Iss. 6, 2012-06 ,pp. : 1822-1828

Oxford University Press

Access to resources Recommend Favorite

Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial

By Fatemi H.M.   Kolibianakis E.M.   Camus M.   Tournaye H.   Donoso P.   Papanikolaou E.   Devroey P.  

Human Reproduction, Vol. 21, Iss. 10, 2006-10 ,pp. : 2628-2632

Oxford University Press

Access to resources Recommend Favorite

Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis

By Kolibianakis E.M.   Venetis C.A.   Papanikolaou E.G.   Diedrich K.   Tarlatzis B.C.   Griesinger G.  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1346-1354

Oxford University Press

Access to resources Recommend Favorite

Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix

By Tavaniotou Asimina   Albano Carola   Smitz Johan   Devroey Paul  

Human Reproduction, Vol. 16, Iss. 4, 2001-04 ,pp. : 663-667

Oxford University Press

Access to resources Recommend Favorite

Endocrinology: Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone

By Pouly Jean Luc  

Human Reproduction, Vol. 11, Iss. 10, 1996-10 ,pp. : 2085-2089

Oxford University Press

Access to resources Recommend Favorite